'%20d='m0%200%2016%2011h61%2061%2061%2061%2060L47%2037h61%2061%2060%2061L16%2063h61%2061%2061%2061%2060L47%2089h61%2061%2060%2061L16%20115h61%2061%2061%2061%2060L47%20141h61%2061%2060%2061L16%20166h61%2061%2061%2061%2060L47%20192h61%2061%2060%2061L16%20218h61%2061%2061%2061%2060z'/%3e%3c/svg%3e)
About
Three national awards in three consecutive years is a rare run during fellowship. Atoosa Ghofranian took Excellence in REI Research in 2023, a Society for Gynecologic Investigation Fellow Scholar award in 2024, and an Early Pregnancy Special Interest Group prize paper award in 2025 — all for work on embryo development, ovarian reserve and pregnancy outcomes, the three variables that decide whether a cycle succeeds.
Her training was New York-weighted, which matters for technique. She earned her MD at Georgetown, completed OB/GYN residency at the Icahn School of Medicine at Mount Sinai and served there as Administrative Chief Resident, then split REI fellowship between Mount Sinai and RMA of New York, one of the highest-volume private IVF programs in the country. Undergraduate work came later than most: an AA in science honors at Santa Ana College, then a magna cum laude BS at UC San Diego.
Clinically she concentrates on the difficult-response patient: diminished ovarian reserve, PCOS, recurrent pregnancy loss, and fertility care for transgender and LGBTQ+ patients — including preservation before gender-affirming treatment. She begins seeing patients at HRC Fertility’s Newport Beach office in summer 2026, working with the Orange County embryology laboratory that has run there since 2000.
Clinical Expertise
- IVF for diminished ovarian reserve: individualized stimulation, antagonist protocols and accumulated-cycle strategies for patients who recruit few follicles
- PCOS management: dose minimization to control OHSS risk, freeze-all strategies when response is excessive, and metabolic co-management
- Egg and embryo freezing: stimulation design and vitrification for medical and elective preservation, including pre-treatment banking for transgender patients
- Recurrent pregnancy loss: genetic, anatomic, endocrine, uterine and thrombophilic evaluation, with attention to embryo quality as a cause — the subject of her prize-winning research
- Embryo development and selection: blastocyst culture and PGT interpretation grounded in published work on embryo development
- LGBTQ+ and transgender fertility care: preservation counseling, donor gamete cycles, reciprocal IVF and gestational carrier paths under California law
Why Choose Dr. Ghofranian
Award-winning research in the exact area that decides your cycle. Ovarian reserve, embryo development, pregnancy loss. Her Early Pregnancy SIG prize paper (2025) is not an abstract in a drawer; it is on the mechanism of early pregnancy failure, which is the question recurrent-loss patients live with.
Fellowship at RMA of New York. RMA is one of the largest ART programs in the eastern US, and Mount Sinai/RMA fellowships are known for lab-adjacent training. Poor responders and complex PCOS cases pass through such programs in volume, so the pattern-recognition transfers to Newport Beach.
Administrative Chief Resident at Mount Sinai. The administrative chief role is systems work: scheduling, quality control, protocol standardization. Patients feel that as fewer logistics failures during monitoring and retrieval.
Transgender fertility care is a named focus, not an accommodation. Banking gametes before gender-affirming treatment requires cycle design, consent and coordination most clinics improvise. It is listed among her clinical interests, alongside an IVF practice built for DOR and PCOS.
A new seat at a mature lab. Newport Beach has had an on-site HRC embryology laboratory since 2000 under board-certified scientific direction, and her summer 2026 arrival means appointments available before the panel fills.
Professional Affiliations
Member of the American Society for Reproductive Medicine and the American College of Obstetricians and Gynecologists; recognition from The Society for Gynecologic Investigation. Awards include Excellence in REI Research (2023), SGS Fellow Scholar (2024) and the Early Pregnancy SIG Prize Paper award (2025). Peer-reviewed publications on embryo development, ovarian reserve and reproductive outcomes, presented at national meetings. Board-eligible in Reproductive Endocrinology and Infertility following Mount Sinai/RMA of New York fellowship.
Suitable For
Poor responders and patients with low AMH or high FSH. Protocols built around a small follicle cohort, with honest expectations about how many eggs a given reserve yields.
PCOS patients worried about hyperstimulation. Dose-conservative strategies, antagonist protocols and freeze-all decisions.
Two or more losses. Evaluation informed by prize-winning research on early pregnancy outcomes.
Transgender patients planning preservation. Gamete banking arranged before gender-affirming therapy, with the fertility implications spelled out.
LGBTQ+ families building with donor gametes or a gestational carrier. Cycles and legal sequencing handled at a California practice where these paths are routine.
Women banking eggs now and deciding later. Stimulation design and vitrification at a lab with 25 years of freezing history.